Multiple antisense oligonucleotides targeted against monoacylglycerol acyltransferase 1 (Mogat1) improve glucose metabolism independently of Mogat1
Objective: Monoacylglycerol acyltransferase (MGAT) enzymes catalyze the synthesis of diacylglycerol from monoacylglycerol. Previous work has suggested the importance of MGAT activity in the development of obesity-related hepatic insulin resistance. Indeed, antisense oligonucleotide (ASO)-mediated kn...
Saved in:
Main Authors: | Andrew J. Lutkewitte (Author), Jason M. Singer (Author), Trevor M. Shew (Author), Michael R. Martino (Author), Angela M. Hall (Author), Mai He (Author), Brian N. Finck (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatic Monoacylglycerol O-acyltransferase 1 as a Promising Therapeutic Target for Steatosis, Obesity, and Type 2 Diabetes
by: Yasuhiro Hayashi, et al.
Published: (2014) -
Involvement of the vagus nerve in the anorectic effect of monoacylglycerol acyltransferase 2 inhibition in mice
by: Kosuke Takemoto, et al.
Published: (2023) -
Regular moderate aerobic exercise improves high-fat diet-induced nonalcoholic fatty liver disease via monoacylglycerol O-acyltransferase 1 pathway suppression
by: Kyung-Wan Baek, et al.
Published: (2020) -
Pharmacokinetics of antisense oligonucleotide drugs
by: M. R. Khaitov, et al.
Published: (2013) -
JTP-103237, a monoacylglycerol acyltransferase inhibitor, prevents fatty liver and suppresses both triglyceride synthesis and de novo lipogenesis
by: Chihiro Okuma, et al.
Published: (2015)